SMALL GAIN FOR EMBRYONIC STEM CELLS
Paralysed rats treated with a cocktail of embryonic stem cells, adult stem cells, proteins and drugs have recovered some movement, say researchers at Johns Hopkins University in Baltimore. Lead researcher Dr Douglas Kerr says that the work is a big step forward towards a cure for spinal cord injury and other kinds of paralysis; clinical trials might be possible within five years. He said the big limitation was lack of federal funding — hundreds of millions will be needed to bring the development through to clinical trials.
Michael Cook edits BioEdge, a bioethics newsletter, and MercatorNet, an on-line magazine whose focus is human dignity. He writes from Sydney, Australia.
Latest posts by Michael Cook (see all)
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Media approaches peak cognitive dissonance over the ‘T’ in LGBT Pride month
The media is approaching peak cognitive dissonance in Pride Month over the issue of transgenderism. On the one hand, Glamour...
The Economist: ‘Global fertility has collapsed’
The Economist, an oracle for politicians, journalists, and economists the world over, has turned bearish on the future of humanity....
Croatia plans to import sperm. No one back home wants to donate
Sperm and egg donation has been legal in Croatia since 2012. But no one has donated. The problem seems to...
Australian woman freed after 20 years after new genetic evidence raised ‘reasonable doubt’
An Australian woman who spent 20 years in jail for murdering her four infant children has been pardoned on the...
Is surrogacy a way of combatting ‘compulsory familialism’?
For people on either side of the debate, surrogacy can seem like a black-and-white issue. Opponents stress human dignity; supporters...
The FDA finally approved Elon Musk’s Neuralink chip for human trials. Have all the concerns been addressed?
Since its founding in 2016, Elon Musk’s neurotechnology company Neuralink has had the ambitious mission to build a next-generation brain...
